Prognostic and clinicopathological significance of MLKL expression in cancer patients: a meta-analysis.

Binwu HuDeyao ShiXiao LvSongfeng ChenQin HuangMao XieZeng-Wu Shao

Published in: BMC cancer (2018)

In conclusion, our meta-analysis suggested that decreased MLKL expression might be a convinced unfavorable prognostic factor that could help the clinical decision-making process.

Keyphrases

prognostic factors
poor prognosis
systematic review
decision making
binding protein
meta analyses
long non coding rna
randomized controlled trial